Laura Clague - May 10, 2022 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
May 10, 2022
Transactions value $
-$47,322
Form type
4
Date filed
5/12/2022, 08:45 PM
Previous filing
Apr 27, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$17.7K -825 -2.18% $21.51 37K May 10, 2022 Direct F1
transaction TVTX Common Stock Sale -$29.6K -1.38K -3.71% $21.51 35.7K May 11, 2022 Direct F1, F2

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.51 to $21.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.